United States Adult Vaccines Market Report 2021

United States Adult Vaccines Market Report 2021

1 Adult Vaccines Overview

1.1 Product Overview and Scope of Adult Vaccines

1.2 Classification of Adult Vaccines

1.2.1 Influenza

1.2.2 Cervical Cancer

1.2.3 Zoster Shingles

1.2.4 Pneumococcal

1.2.5 Meningococcal

1.2.6 MMRV

1.2.7 Hepatitis

1.2.8 DTP

1.2.9 Travel and Miscellaneous

1.3 Applications of Adult Vaccines

1.3.1 Medical care

1.3.2 Healthy

1.3.3 Hospita

1.4 USA Market Size (Value and Volume) of Adult Vaccines (2011-2021)

1.4.1 USA Adult Vaccines Sales, Revenue and Price (2011-2021)

1.4.2 USA Adult Vaccines Sales and Growth Rate (2011-2021)

1.4.3 USA Adult Vaccines Revenue and Growth Rate (2011-2021)

2 USA Adult Vaccines Competition by Manufacturers

2.1 USA Adult Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Adult Vaccines Revenue and Share by Manufactures (2015 and 2016)

3 USA Adult Vaccines (Volume and Value) by Type

3.1 USA Adult Vaccines Sales and Market Share by Type (2011-2021)

3.2 USA Adult Vaccines Revenue and Market Share by Type (2011-2021)

4 USA Adult Vaccines (Volume) by Application

5 USA Adult Vaccines Manufacturers Analysis

5.1 GlaxoSmithKline

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Adult Vaccines Product Type and Technology

5.1.2.1 Influenza

5.1.2.2 Cervical Cancer

5.1.3 Adult Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

5.2 Sanofi Pasteur

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharma & Healthcare Product Type and Technology

5.2.2.1 Influenza

5.2.2.2 Cervical Cancer

5.2.3 Pharma & Healthcare Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

5.3 Merck

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Merck Product Type and Technology

5.3.2.1 Influenza

5.3.2.2 Cervical Cancer

5.3.3 Merck Sales, Revenue, Price of Merck (2015 and 2016)

5.4 Novartis

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Product Type and Technology

5.4.2.1 Influenza

5.4.2.2 Cervical Cancer

5.4.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)

5.5 Pfizer

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Pfizer Product Type and Technology

5.5.2.1 Influenza

5.5.2.2 Cervical Cancer

5.5.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.6 bioCSL (Seqirus)

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 bioCSL (Seqirus) Product Type and Technology

5.6.2.1 Influenza

5.6.2.2 Cervical Cancer

5.6.3 bioCSL (Seqirus) Sales, Revenue, Price of bioCSL (Seqirus) (2015 and 2016)

5.7 Protein Sciences

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Protein Sciences Product Type and Technology

5.7.2.1 Influenza

5.7.2.2 Cervical Cancer

5.7.3 Protein Sciences Sales, Revenue, Price of Protein Sciences (2015 and 2016)

6 Adult Vaccines Technology and Development Trend

6.1 Adult Vaccines Technology Analysis

6.2 Adult Vaccines Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Adult Vaccines

Table Classification of Adult Vaccines

Figure USA Sales Market Share of Adult Vaccines by Type in 2015

Figure Influenza Picture

Figure Cervical Cancer Picture

Figure Zoster Shingles Picture

Figure Pneumococcal Picture

Figure Meningococcal Picture

Figure MMRV Picture

Figure Hepatitis Picture

Figure DTP Picture

Figure Travel and Miscellaneous Picture

Table Applications of Adult Vaccines

Figure USA Sales Market Share of Adult Vaccines by Application in 2015

Figure Medical care Examples

Figure Healthy Examples

Figure Hospita Examples

Table USA Adult Vaccines Sales, Revenue and Price (2011-2021)

Figure USA Adult Vaccines Sales and Growth Rate (2011-2021)

Figure USA Adult Vaccines Revenue and Growth Rate (2011-2021)

Table USA Adult Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Adult Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Adult Vaccines Sales Share by Manufacturers

Figure 2016 Adult Vaccines Sales Share by Manufacturers

Table USA Adult Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Adult Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Adult Vaccines Revenue Share by Manufacturers

Table 2016 USA Adult Vaccines Revenue Share by Manufacturers

Table USA Adult Vaccines Sales and Market Share by Type (2011-2021)

Table USA Adult Vaccines Sales Share by Type (2011-2021)

Figure Sales Market Share of Adult Vaccines by Type (2011-2021)

Figure USA Adult Vaccines Sales Growth Rate by Type (2011-2021)

Table USA Adult Vaccines Revenue and Market Share by Type (2011-2021)

Table USA Adult Vaccines Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Adult Vaccines by Type (2011-2021)

Figure USA Adult Vaccines Revenue Growth Rate by Type (2011-2021)

Table USA Adult Vaccines Sales and Market Share by Application (2011-2021)

Table USA Adult Vaccines Sales Share by Application (2011-2021)

Figure Sales Market Share of Adult Vaccines by Application (2011-2021)

Figure USA Adult Vaccines Sales Growth Rate by Application (2011-2021)

Table GlaxoSmithKline Basic Information List

Table Adult Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Sanofi Pasteur Basic Information List

Table Adult Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

Table Merck Basic Information List

Table Adult Vaccines Sales, Revenue, Price of Merck (2015 and 2016)

Table Novartis Basic Information List

Table Adult Vaccines Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer Basic Information List

Table Adult Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

Table bioCSL (Seqirus) Basic Information List

Table Adult Vaccines Sales, Revenue, Price of bioCSL (Seqirus) (2015 and 2016)

Table Protein Sciences Basic Information List

Table Adult Vaccines Sales, Revenue, Price of Protein Sciences (2015 and 2016)